Fundraising Fox

Exagen

NASDAQ: XGN

Vista, US · Delaware corporation · 7 known investors

exagen.com ↗

Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression. The company serves healthcare professionals and patients with chronic autoimmune conditions.

BiotechDigital HealthHealthtechMedical Devicesin /exageninc@ExagenInc

Founders & leadership

TD
Thierry DervieuxExecutive Officer
WS
Wendy SwedickExecutive Officer
AW
Arthur WeinsteinDirector
JL
James L.L. TullisDirector
FR
Fortunato R. RoccaExecutive Officer, Director
JM
John M. RadakDirector
BB
Brian BirkDirector
EP
Ebetuel PallaresDirector
FW
Frank WitneyDirector

Investors · 7

Cottonwood Technology FundSanta Fe · $1M – $25M
EPIC VENTURESSalt Lake City
H.I.G. CapitalMiami
H.I.G. HealthBridge PartnersMiami · $5M – $40M
Sun Mountain CapitalSanta Fevia Brian Birk · board
Tullis Health InvestorsPalm Beach Gardens · $500K – $10M
TullisreportedPalm Beach Gardens

Reported raises · per SEC filings

Form D private placements
▶$6.6MraisedFeb 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel C. BurrellDirector
  • Thierry DervieuxExecutive Officer
  • Fortunato R. RoccaExecutive Officer, Director
  • Ebetuel PallaresDirector
  • James L.L. TullisDirector
  • Kamal AdawiExecutive Officer
  • Arthur WeinsteinDirector
  • Brian BirkDirector
Offering amount
$16M
Amount sold
$6.6M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedMay 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James L.L. TullisDirector
  • Mark HazeltineExecutive Officer
  • Fortunato R. RoccaExecutive Officer, Director
  • Ebetuel PallaresDirector
  • Frank WitneyDirector
  • John M. RadakDirector
  • Thierry DervieuxExecutive Officer
  • Arthur WeinsteinDirector
  • Brian BirkDirector
Offering amount
$13.2M
Amount sold
$3.7M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedApr 2017 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ebetuel PallaresDirector
  • James L.L. TullisDirector
  • Brian BirkDirector
  • Wendy SwedickExecutive Officer
  • Thierry DervieuxExecutive Officer
  • John M. RadakDirector
  • Frank WitneyDirector
  • Fortunato R. RoccaExecutive Officer, Director
  • Arthur WeinsteinDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ebetuel PallaresDirector
  • Brian BirkDirector
  • Thierry DervieuxExecutive Officer
  • John M. RadakDirector
  • Wendy SwedickExecutive Officer
  • Arthur WeinsteinDirector
  • Frank WitneyDirector
  • Fortunato R. RoccaExecutive Officer, Director
  • James L.L. TullisDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$995.9KraisedFeb 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wendy SwedickExecutive Officer
  • James L.L. TullisDirector
  • Arthur WeinsteinDirector
  • Fortunato R. RoccaExecutive Officer, Director
  • Ebetuel PallaresDirector
  • Thierry DervieuxExecutive Officer
  • John M. RadakDirector
  • Frank WitneyDirector
  • Brian BirkDirector
Offering amount
$995.9K
Amount sold
$995.9K
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$995.9KraisedDec 2016 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James L.L. TullisDirector
  • Ebetuel PallaresDirector
  • Wendy SwedickExecutive Officer
  • Brian BirkDirector
  • Fortunato R. RoccaExecutive Officer, Director
  • Frank WitneyDirector
  • Arthur WeinsteinDirector
  • Thierry DervieuxExecutive Officer
  • John M. RadakDirector
Offering amount
$995.9K
Amount sold
$995.9K
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$995.9KraisedNov 2016 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank WitneyDirector
  • Brian BirkDirector
  • Ebetuel PallaresDirector
  • James L.L. TullisDirector
  • Arthur WeinsteinDirector
  • Fortunato R. RoccaExecutive Officer, Director
  • Thierry DervieuxExecutive Officer
  • Wendy SwedickExecutive Officer
  • John M. RadakDirector
Offering amount
$995.9K
Amount sold
$995.9K
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$995.9KraisedOct 2016 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thierry DervieuxExecutive Officer
  • Wendy SwedickExecutive Officer
  • Arthur WeinsteinDirector
  • James L.L. TullisDirector
  • Fortunato R. RoccaExecutive Officer, Director
  • John M. RadakDirector
  • Brian BirkDirector
  • Ebetuel PallaresDirector
  • Frank WitneyDirector
Offering amount
$995.9K
Amount sold
$995.9K
First sale
Oct 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news